BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25770781)

  • 21. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD
    Wang X; Ahn YM; Lentscher AG; Lister JS; Brothers RC; Kneen MM; Gerratana B; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4426-4430. PubMed ID: 28827112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
    Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Vanheusden V; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2695-8. PubMed ID: 12217356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Gasse C; Huteau V; Douguet D; Munier-Lehmann H; Pochet S
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
    Lu W; Baig IA; Sun HJ; Cui CJ; Guo R; Jung IP; Wang D; Dong M; Yoon MY; Wang JG
    Eur J Med Chem; 2015 Apr; 94():298-305. PubMed ID: 25771108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methionine sulfoximine resistance in Mycobacterium tuberculosis is due to a single nucleotide deletion resulting in increased expression of the major glutamine synthetase, GlnA1.
    Carroll P; Waddell SJ; Butcher PD; Parish T
    Microb Drug Resist; 2011 Sep; 17(3):351-5. PubMed ID: 21875360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antitubercular screening of imidazole derivatives.
    Pandey J; Tiwari VK; Verma SS; Chaturvedi V; Bhatnagar S; Sinha S; Gaikwad AN; Tripathi RP
    Eur J Med Chem; 2009 Aug; 44(8):3350-5. PubMed ID: 19272678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.
    Hung AW; Silvestre HL; Wen S; George GP; Boland J; Blundell TL; Ciulli A; Abell C
    ChemMedChem; 2016 Jan; 11(1):38-42. PubMed ID: 26486566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 96-well microtiter plate assay for high-throughput screening of Mycobacterium tuberculosis dTDP-d-glucose 4,6-dehydratase inhibitors.
    Shi X; Sha S; Liu L; Li X; Ma Y
    Anal Biochem; 2016 Apr; 498():53-8. PubMed ID: 26778528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
    Velaparthi S; Brunsteiner M; Uddin R; Wan B; Franzblau SG; Petukhov PA
    J Med Chem; 2008 Apr; 51(7):1999-2002. PubMed ID: 18335974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C; Chollet A; Rodriguez F; Inard C; Pasca MR; Lherbet C; Baltas M
    Eur J Med Chem; 2012 Jun; 52():275-83. PubMed ID: 22483635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rapid, asymmetric synthesis of the decahydrofluorene core of the hirsutellones.
    Tilley SD; Reber KP; Sorensen EJ
    Org Lett; 2009 Feb; 11(3):701-3. PubMed ID: 19119873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.
    Ryan A; Polycarpou E; Lack NA; Evangelopoulos D; Sieg C; Halman A; Bhakta S; Eleftheriadou O; McHugh TD; Keany S; Lowe ED; Ballet R; Abuhammad A; Jacobs WR; Ciulli A; Sim E
    Br J Pharmacol; 2017 Jul; 174(14):2209-2224. PubMed ID: 28380256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quercetin 3-O-glucoside recovered from the wild Egyptian Sahara plant, Euphorbia paralias L., inhibits glutamine synthetase and has antimycobacterial activity.
    Safwat NA; Kashef MT; Aziz RK; Amer KF; Ramadan MA
    Tuberculosis (Edinb); 2018 Jan; 108():106-113. PubMed ID: 29523309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase.
    Luciani R; Saxena P; Surade S; Santucci M; Venturelli A; Borsari C; Marverti G; Ponterini G; Ferrari S; Blundell TL; Costi MP
    J Med Chem; 2016 Oct; 59(19):9269-9275. PubMed ID: 27589670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse heterocyclic scaffolds as allosteric inhibitors of AKT.
    Kettle JG; Brown S; Crafter C; Davies BR; Dudley P; Fairley G; Faulder P; Fillery S; Greenwood H; Hawkins J; James M; Johnson K; Lane CD; Pass M; Pink JH; Plant H; Cosulich SC
    J Med Chem; 2012 Feb; 55(3):1261-73. PubMed ID: 22248236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of 9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes.
    Colombo M; Vallese S; Peretto I; Jacq X; Rain JC; Colland F; Guedat P
    ChemMedChem; 2010 Apr; 5(4):552-8. PubMed ID: 20186914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase.
    Van Calenbergh S; Pochet S; Munier-Lehmann H
    Curr Top Med Chem; 2012; 12(7):694-705. PubMed ID: 22283813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.